Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
216.40    -0.60 (-0.28%)
Bid:
216.20
Ask:
216.80
Spread: 0.60 (0.278%)
Market Cap: £2.21b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Termination of Cash Tender Offer

9 Jun 2020 07:39

RNS Number : 3760P
Helios Towers PLC
09 June 2020
 

This announcement contains inside information for the purpose of Article 7 of the Market Abuse Regulation (EU) 596/2014

 

NOT FOR DISTRIBUTION IN OR INTO ANY JURISDICTION OR TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION IN WHICH SUCH DISTRIBUTION IS UNLAWFUL

 

 

HELIOS TOWERS ANNOUNCES THE TERMINATION OF ITS CASH TENDER OFFER FOR UP TO U.S.$325 MILLION AGGREGATE PRINCIPAL AMOUNT OF 9.125% SENIOR NOTES DUE 2022 AND INTENTION TO ISSUE A NOTICE OF CONDITIONAL REDEMPTION FOR ALL OUTSTANDING EXISTING NOTES

 

June 9, 2020 - Further to its previous announcement dated June 8, 2020, HTA Group, Ltd (the "Offeror"), an indirect wholly owned subsidiary of Helios Towers plc (the "Company"), announces the termination of its offer to purchase for cash (the "Tender Offer") up to U.S.$325 million aggregate principal amount of the 9.125% Senior Notes due 2022 issued by the Offeror (the "Existing Notes").

 

The Tender Offer was made upon the terms and subject to the conditions set forth in the offer to purchase dated June 8, 2020 (the "Offer to Purchase").

 

Concurrently with the Tender Offer launch announcement, the Offeror had also announced an offering of new notes (the "New Notes Offering"), to be guaranteed on a senior basis by the Company and certain of its direct and indirect subsidiaries. The proceeds from the New Notes Offering are expected to be sufficient to, among other uses of proceeds, pay the redemption price of 102.281% of the principal amount (plus any accrued interest) in connection with an optional redemption of the entire aggregate principal amount of Existing Notes outstanding pursuant to the terms of the indenture governing the Existing Notes. Consequently, the Offeror is cancelling the Tender Offer and intends to issue a notice of conditional redemption on June 9, 2020 to instead redeem all outstanding Existing Notes. The redemption will be subject to the successful completion of the New Notes Offering on terms acceptable to the Company and the Offeror.

 

Any Existing Notes in respect of which tender instructions have been submitted prior to this announcement will be unblocked in the relevant clearing system and will be promptly returned.

 

This announcement is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, any security. No offer, solicitation, or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be unlawful.

 

The Offer to Purchase has not be filed or reviewed by any U.S. federal or State or any foreign securities commission or regulatory authority, nor has any such commission or authority passed upon the accuracy or adequacy of the Offer to Purchase. Any representation to the contrary is unlawful and may be a criminal offense.

 

The New Notes and the guarantees in respect thereof have not been and will not be registered under the United States Securities Act of 1933. No action has been or will be taken in any jurisdiction in relation to the New Notes to permit a public offering of securities.

 

The distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which they are released, published or distributed, should inform themselves about, and observe, such restrictions. Any failure to comply with these restrictions may constitute a violation of the laws of any such jurisdiction.

 

Forward-Looking Information

 

Certain statements included herein may constitute forward-looking statements within the meaning of the securities laws of certain jurisdictions. Certain such forward-looking statements can be identified by the use of forward-looking terminology such as "believes", "expects", "may", "are expected to", "intends", "will", "will continue", "should", "would be", "seeks", "anticipates" or similar expressions or the negative thereof or other variations thereof or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the Offeror concerning, among other things, the results in relation to operations, financial condition, liquidity, prospects, growth and strategies of the Offeror and the industry in which it operates. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.

 

These forward-looking statements speak only as of the date of this announcement. The Offeror does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required under Rule 14e-1 under the United States Securities Exchange Act of 1934.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TENEAKKNEAFEEEA
Date   Source Headline
17th Jun 20267:00 amRNSTransaction in Own Shares
15th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20263:41 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20263:26 pmRNSTotal Voting Rights
28th May 202610:15 amRNSHolding(s) in Company
26th May 20267:00 amRNSTransaction in Own Shares
20th May 202612:13 pmRNSHolding(s) in Company
20th May 20267:00 amRNSHolding(s) in Company
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20261:10 pmRNSDirector/PDMR Shareholding
14th May 20261:12 pmRNS2026 Annual General Meeting Results
11th May 20267:37 amRNSTransaction in Own Shares
8th May 20267:11 amRNSHolding(s) in Company
7th May 20267:00 amRNSQ1 2026 Results
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20268:47 amRNSHolding(s) in Company
30th Apr 20264:03 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 202612:20 pmRNSHolding(s) in Company
8th Apr 202610:49 amRNSNotice of Q1 2026 Results Date & Conference Call
7th Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20262:34 pmRNSTotal Voting Rights
30th Mar 20269:50 amRNSAnnual Report and Notice of AGM
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 202612:00 pmRNSDirector/PDMR Shareholding
25th Mar 20266:08 pmRNSHelios Towers announces pricing of Senior Notes
24th Mar 202611:43 amRNSLAUNCH OF OFFER OF SENIOR NOTES
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20263:14 pmRNSDirector/PDMR Shareholding
16th Mar 20263:14 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSFull Year Results 2025
12th Mar 20267:00 amRNSFull Year Results 2025
9th Mar 20264:15 pmRNSDirectorate change
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20264:19 pmRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.